Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers

Fig. 3

Genomic alterations in metaplastic PDXs and comparison with other TNBC subtypes. a Major genomic alterations (mutations and copy number alterations) in nine metaplastic PDXs with histological characteristics and transcriptomic classification. b Percentage of major genomic alterations in metaplastic TNBC PDXs versus the other histologic subtypes; *p = 0.01, Fisher’s test

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us